astramembrangenin,
cycloastragenol,
cyclogalegigenin,
GRN510,
Cycloastragenol,
Astramembrangenin,
78574-94-4,
UNII-X37D9F2L0V,
Cyclogalegigenin,
X37D9F2L0V,
Cycloastragenol, >=98% (HPLC),
(3beta,6alpha,9beta,16beta,20R,24S)-20,24-epoxy-9,19-cyclolanostane-3,6,16,25-tetrol,
84605-18-5,
Cyclosiversigenin,
SCHEMBL365107,
CHEBI:71314,
KS-00000TRY,
WENNXORDXYGDTP-UOUCMYEWSA-,
MFCD24849201,
ZINC68248924,
AKOS030524082,
DS-19394,
C3469,
(3beta,6alpha,16beta,20R,24S)-20,24-Epoxy-9,19-cyclolanostane-3,6,16,25-tetrol,
(2aR,3R,4S,5aS,5bS,7S,7aR,9S,11aR,12aS)-3-((2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-2a,5a,8,8-tetramethyltetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthrene-4,7,9-triol,
(3beta,6alpha,16beta,20R,24S)-20,24-Epoxy-9,19-cyclolanostane-3,6,16,25-tetrol / Astramembrangenin,
InChI=1/C30H50O5/c1-24(2)20(33)8-11-30-16-29(30)13-12-26(5)23(28(7)10-9-21(35-28)25(3,4)34)18(32)15-27(26,6)19(29)14-17(31)22(24)30/h17-23,31-34H,8-16H2,1-7H3/t17-,18-,19-,20-,21-,22-,23-,26+,27-,28+,29-,30+/m0/s1,
ACN-047761,